BioArctic (Sweden) Market Value
| BIOA-B Stock | SEK 194.40 5.30 2.80% |
| Symbol | BioArctic |
BioArctic 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to BioArctic's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of BioArctic.
| 10/28/2024 |
| 11/27/2024 |
If you would invest 0.00 in BioArctic on October 28, 2024 and sell it all today you would earn a total of 0.00 from holding BioArctic AB or generate 0.0% return on investment in BioArctic over 30 days. BioArctic is related to or competes with Oncopeptides, Camurus AB, Hansa Biopharma, and Cantargia. BioArctic AB , a research intensive biopharmaceutical company, develops disease modifying treatments and diagnostics for... More
BioArctic Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure BioArctic's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess BioArctic AB upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 3.2 | |||
| Information Ratio | 0.0449 | |||
| Maximum Drawdown | 39.02 | |||
| Value At Risk | (4.55) | |||
| Potential Upside | 6.39 |
BioArctic Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for BioArctic's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as BioArctic's standard deviation. In reality, there are many statistical measures that can use BioArctic historical prices to predict the future BioArctic's volatility.| Risk Adjusted Performance | 0.0631 | |||
| Jensen Alpha | 0.3989 | |||
| Total Risk Alpha | (0.41) | |||
| Sortino Ratio | 0.0677 | |||
| Treynor Ratio | (0.62) |
BioArctic AB Backtested Returns
BioArctic appears to be very steady, given 3 months investment horizon. BioArctic AB secures Sharpe Ratio (or Efficiency) of 0.0579, which signifies that the company had a 0.0579% return per unit of risk over the last 3 months. We have found twenty-eight technical indicators for BioArctic AB, which you can use to evaluate the volatility of the firm. Please makes use of BioArctic's Risk Adjusted Performance of 0.0631, mean deviation of 2.73, and Downside Deviation of 3.2 to double-check if our risk estimates are consistent with your expectations. On a scale of 0 to 100, BioArctic holds a performance score of 4. The firm shows a Beta (market volatility) of -0.54, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning BioArctic are expected to decrease at a much lower rate. During the bear market, BioArctic is likely to outperform the market. Please check BioArctic's total risk alpha, treynor ratio, and the relationship between the jensen alpha and sortino ratio , to make a quick decision on whether BioArctic's price patterns will revert.
Auto-correlation | -0.62 |
Very good reverse predictability
BioArctic AB has very good reverse predictability. Overlapping area represents the amount of predictability between BioArctic time series from 28th of October 2024 to 12th of November 2024 and 12th of November 2024 to 27th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of BioArctic AB price movement. The serial correlation of -0.62 indicates that roughly 62.0% of current BioArctic price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.62 | |
| Spearman Rank Test | -0.17 | |
| Residual Average | 0.0 | |
| Price Variance | 264.92 |
BioArctic AB lagged returns against current returns
Autocorrelation, which is BioArctic stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting BioArctic's stock expected returns. We can calculate the autocorrelation of BioArctic returns to help us make a trade decision. For example, suppose you find that BioArctic has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
BioArctic regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If BioArctic stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if BioArctic stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in BioArctic stock over time.
Current vs Lagged Prices |
| Timeline |
BioArctic Lagged Returns
When evaluating BioArctic's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of BioArctic stock have on its future price. BioArctic autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, BioArctic autocorrelation shows the relationship between BioArctic stock current value and its past values and can show if there is a momentum factor associated with investing in BioArctic AB.
Regressed Prices |
| Timeline |
Thematic Opportunities
Explore Investment Opportunities
Other Information on Investing in BioArctic Stock
BioArctic financial ratios help investors to determine whether BioArctic Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in BioArctic with respect to the benefits of owning BioArctic security.